Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

National trends in the treatment of attention deficit hyperactivity disorder.

Olfson M, Gameroff MJ, Marcus SC, Jensen PS.

Am J Psychiatry. 2003 Jun;160(6):1071-7.

PMID:
12777264
2.

National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Comer JS, Olfson M, Mojtabai R.

J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1001-10. doi: 10.1016/j.jaac.2010.07.007.

3.

National trends in the outpatient treatment of anxiety disorders.

Olfson M, Marcus SC, Wan GJ, Geissler EC.

J Clin Psychiatry. 2004 Sep;65(9):1166-73.

PMID:
15367042
4.

National trends in the outpatient treatment of depression.

Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA.

JAMA. 2002 Jan 9;287(2):203-9.

PMID:
11779262
5.

National trends in the use of outpatient psychotherapy.

Olfson M, Marcus SC, Druss B, Pincus HA.

Am J Psychiatry. 2002 Nov;159(11):1914-20.

PMID:
12411228
6.
7.

Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.

Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.

Pediatrics. 2002 May;109(5):733-9.

PMID:
11986429
8.

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.

Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA.

Arch Pediatr Adolesc Med. 1999 Dec;153(12):1257-63.

PMID:
10591302
9.
10.

Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.

Robison LM, Sclar DA, Skaer TL, Galin RS.

Int Clin Psychopharmacol. 2004 Jan;19(1):17-22.

PMID:
15101565
11.

National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.

Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M.

Arch Gen Psychiatry. 2007 Sep;64(9):1032-9.

PMID:
17768268
12.

Medication management of stimulants in pediatric practice settings: a national perspective.

Hoagwood K, Jensen PS, Feil M, Vitiello B, Bhatara VS.

J Dev Behav Pediatr. 2000 Oct;21(5):322-31.

PMID:
11064959
14.

Trends in recognition of and service use for attention-deficit hyperactivity disorder in Britain, 1999-2004.

Sayal K, Ford T, Goodman R.

Psychiatr Serv. 2010 Aug;61(8):803-10. doi: 10.1176/appi.ps.61.8.803.

PMID:
20675839
15.

Treatment services for children with ADHD: a national perspective.

Hoagwood K, Kelleher KJ, Feil M, Comer DM.

J Am Acad Child Adolesc Psychiatry. 2000 Feb;39(2):198-206. Review.

PMID:
10673831
16.

Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program.

Zima BT, Bussing R, Tang L, Zhang L, Ettner S, Belin TR, Wells KB.

J Am Acad Child Adolesc Psychiatry. 2010 Dec;49(12):1225-37, 1237.e1-11. doi: 10.1016/j.jaac.2010.08.012.

17.

Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.

Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC.

Arch Pediatr Adolesc Med. 1999 Oct;153(10):1039-45.

PMID:
10520611
18.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

19.
20.

Stimulant medication use in children: a 12-year perspective.

Zuvekas SH, Vitiello B.

Am J Psychiatry. 2012 Feb;169(2):160-6.

Items per page

Supplemental Content

Support Center